Carlos Ernesto Fernandez‐Garcia

Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024

Mónica López‐Lacort, Cintia Muñoz-Quiles, Ainara Mira‐Iglesias et al. · Eurosurveillance · 2024 · 174 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

Galectin‐3, a Biomarker Linking Oxidative Stress and Inflammation With the Clinical Outcomes of Patients With Atherothrombosis

Julio Madrigal‐Matute, Jes S. Lindholt, Carlos Ernesto Fernandez‐Garcia et al. · Journal of the American Heart Association · 2014 · 148 citations · Full text

Veterinary Medicine, Cardiology, Immunology +17

HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis

Julio Madrigal‐Matute, Carlos Ernesto Fernandez‐Garcia, Carmen Gómez‐Guerrero et al. · Cardiovascular Research · 2012 · 77 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice

Carlos Tarín, Carlos Ernesto Fernandez‐Garcia, Elena Burillo et al. · Cardiovascular Research · 2016 · 50 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +17

Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis

Nuria Beneit, Carlos Ernesto Fernandez‐Garcia, José Luis Martı́n-Ventura et al. · Cardiovascular Diabetology · 2016 · 40 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +13